Carbon dioxide external administration device

ABSTRACT

The present invention provides a carbon dioxide external administration device according to which assured cosmetic and medical effects can be readily obtained. This administration device comprises a sealing enclosure member capable of sealing a body surface from the outside air, a supply means for supplying carbon dioxide into the inside of the sealing enclosure member, and an absorption aid that assists transdermal or transmucosal absorption of the carbon dioxide inside the sealing enclosure member. The administration device may further have a carbon dioxide amount indicator that expands upon carbon dioxide being supplied into the sealing enclosure member, and contracts by the decrease of carbon dioxide.

TECHNICAL FIELD

The present invention relates to a carbon dioxide externaladministration device according to which cosmetic and medical effectsare readily obtained.

BACKGROUND ART

It is disclosed in Japanese Patent Application Laid-open No. 2000-319187that compositions for transdermal or transmucosal absorption of carbondioxide, that are viscous compositions containing carbon dioxide in theform of bubbles, are effective in general with conditions such as thefollowing:

(1) itching accompanying mucocutaneous diseases or mucocutaneousdisorders such as athlete's foot, insect bite, atopic dermatitis,nummular eczema, xeroderma, seborrheic eczema, urticaria, prurigo,housewives' eczema, acne vulgaris, impetigo, folliculitis, carbuncle,furunculosis, phlegmon, pyoderma, psoriasis, ichthyosis, palmoplantarkeratoderma, lichen, pityriasis, wound, burn, rhagades, erosion andchilblain; mucocutaneous injuries such as decubitus ulcer, wound, burn,angular stomatitis, stomatitis, skin ulcer, rhagades, erosion, chilblainand gangrene;

(2) incomplete taking of skin grafts, skin flaps etc.;

(3) dental diseases such as gingivitis, alveolar pyorrhea, dentureulcers, nigricans gingiva and stomatitis;

(4) skin ulcers, cryesthesia and numbness caused by peripheralcirculatory disorders such as thromboangitis obliterans,arteriolosclerosis obliterans, diabetic peripheral circulatory disordersand lower limb varicosis;

(5) musculoskeletal diseases such as chronic rheumatoid arthritis,cervico-omo-brachial syndrome, myalgia, arthralgia and lumbago;

(6) nervous system diseases such as neuralgia, polyneuritis and subacutemyelo-optic neuropathy;

(7) keratoses such as psoriasis, corns, calluses, ichthyosis,palmoplantar keratoderma, lichen and pityriasis;

(8) suppurative skin diseases such as acne vulgaris, impetigo,folliculitis, carbuncles, furuncles, phlegmon, pyoderma and suppurativeeczema;

(9) suppression of hair re-growth after depilation (treatment ofunwanted hair);

(10) cosmetic troubles with the skin or hair such as freckles, roughskin, loss of clarity of the skin, loss of elasticity or luster of theskin, and loss of glossiness of the hair, and partial obesity.

However, to obtain cosmetic or medical effects using such a conventionalcomposition for transdermal or transmucosal absorption of carbondioxide, the composition must be used in large quantities for a longtime period, and considering this the effects are weak. For example, toobtain a face slimming effect using the composition, for example 26.2 gper day must be used for one month. Furthermore, such a composition hashigh viscosity, and hence is difficult to remove from the skin ormucosae after use, and thus use is bothersome.

On the other hand, a poultice for obtaining a blood circulationpromoting effect using carbon dioxide gas (hereinafter used to be thesame meaning as carbon dioxide) is proposed in Japanese PatentApplication Laid-open No. 62-286922.

With this poultice, a cloth containing water is placed onto a clothcontaining a carbonate and an organic acid to generate carbon dioxidegas, which is dissolved in the water contained in the cloth and is thusused as dissolved carbon dioxide gas; however, the reaction between acarbonate and an organic acid is generally very rapid, and hence theamount of carbon dioxide discharged into the atmosphere is greater thanthe amount dissolved in the water, and thus cosmetic or medical effectsdue to transdermal or transmucosal absorption of carbon dioxide cannotreally be expected.

In view of this state of affairs, it is an object of the presentinvention to provide a carbon dioxide external administration deviceaccording to which cosmetic and medical effects are readily obtained.

DISCLOSURE OF THE INVENTION

To attain the above object, the following technical means are adoptedwith the present invention.

That is, a carbon dioxide external administration device of the presentinvention is characterized by comprising a sealing enclosure membercapable of sealing a body surface from the outside air, a supply meansfor supplying carbon dioxide into the inside of the sealing enclosuremember, and an absorption aid that assists transdermal or transmucosalabsorption of the carbon dioxide inside the sealing enclosure member.

With carbon dioxide, in a gaseous form, the efficiency of transdermal ortransmucosal absorption is generally very low, but by applying a carbondioxide absorption aid to skin or mucosae, and sealing the skin ormucosae and exposing the skin or mucosae to carbon dioxide for a certaintime, the carbon dioxide is transdermally or transmucosally absorbedefficiently, and hence strong cosmetic and medical effects are obtainedin a short period of time.

In the present invention, ‘sealing enclosure member’ means a member thatis capable of sealing a body surface which is part or all of a humanbody, and is capable of holding therein a certain amount of a gas, withthis gas not leaking out or leaking out only slightly.

In the present invention, there are no particular limitations on thecarbon dioxide supply means, so long as this means can supply gaseouscarbon dioxide into the inside of the sealing enclosure member; suchsupply means include, for example, ones that have carbon dioxide storedtherein, with it being possible to release the carbon dioxide whenrequired, such as a carbon dioxide gas cylinder, and ones that generatecarbon dioxide when required through reaction between an acid and acarbonate.

In the present invention, carbon dioxide ‘absorption aid’ means amaterial that contains a carbon dioxide-dissolving medium such as water,an alcohol, oils and fats or a wax, and adheres to the skin or mucosaeby being applied thereon, patched thereon or the like in accordance withthe form, properties and so on of the absorption aid, thus forming alayer containing the carbon dioxide-dissolving medium on the skin ormucosae.

It is preferable for the carbon dioxide external administration deviceof the present invention to have a carbon dioxide amount indicator thatexpands upon carbon dioxide being supplied into the sealing enclosuremember, and contracts by the decrease of carbon dioxide.

It is preferable for the sealing enclosure member to have theaforementioned carbon dioxide amount indicator, since then as the carbondioxide filled into the sealing enclosure member is transdermally ortransmucosally absorbed through the absorption aid, the carbon dioxideamount indicator, which was initially expanded, contracts, whereby itcan easily be understood that the carbon dioxide is being transdermallyor transmucosally absorbed even without specialized knowledge or thelike. Furthermore, the aforementioned indicator has a simple structureand hence little failure or the like, and moreover can be made from amaterial such as a balloon and hence is inexpensive.

With the carbon dioxide external administration device of the presentinvention, it is preferable for the absorption aid to contain at leastone carbon dioxide-dissolving medium selected from the group consistingof water, alcohols having a high vaporization temperature, and oils andfats.

Carbon dioxide dissolves in water, alcohols, oils and fats and waxes,and hence one or more of these can be used as a carbondioxide-dissolving medium of the absorption aid. However, it ispreferable for an alcohol to have a vaporization temperature as high aspossible. An alcohol that vaporizes at the skin temperature of a humanor a temperature lower than this is undesirable, since it will bedifficult for the required amount to be retained on the skin or mucosae.Oils and fats may be liquid, or may be semi-solid as with a butter orthe like, so long as the oil or the fat can be thinly spread over theskin or mucosae.

With the carbon dioxide external administration device of the presentinvention, it is preferable for the carbon dioxide absorption aid to bea sheet-like product impregnated with a liquid containing at leastwater.

If the carbon dioxide absorption aid is a sheet-like product impregnatedwith a liquid containing at least water, then the carbon dioxideabsorption aid need merely be patched on the skin or mucosae in use andthen peeled off after use, and hence it can be used very simply.Moreover, even if the amount of the liquid impregnated into thesheet-like product is low, repeated use is possible merely byreplenishing the required amount of the liquid, and it is therefore veryeconomical.

With the carbon dioxide external administration device of the presentinvention, it is preferable for the carbon dioxide absorption aid tocontain a carbon dioxide-dissolving medium comprising a viscous materialcontaining at least water.

When the carbon dioxide absorption aid contains a carbondioxide-dissolving medium comprising a viscous material containing atleast water, the carbon dioxide absorption aid can be applied even to asite that is not flat, and will not run off after having been appliedonto the skin or mucosae, and will thus assist transdermal ortransmucosal absorption of the carbon dioxide continually and reliably.

With the carbon dioxide external administration device of the presentinvention, it is preferable for the aforementioned carbondioxide-dissolving medium comprising a viscous material containing atleast water to contain at least one thickener selected from the groupconsisting of sodium alginate, propylene glycol alginate, carrageenan,sodium hyaluronate, pectin, polyvinyl alcohol and polyvinyl pyrrolidone.

The aforementioned thickeners will give the viscous material therequired viscosity when used in a small amount, have high affinity withskin and mucosae, and have good feeling in use, and hence can besuitably used with a cosmetic or medical purpose.

With the carbon dioxide external administration device of the presentinvention, it is preferable for the carbon dioxide-dissolving medium tocomprise at least a calcium alginate hydrogel.

Calcium alginate forms a relatively tough hydrogel, and has highaffinity with skin and mucosae and wound surfaces, protecting the same.Moreover, in the case that the carbon dioxide-dissolving medium of thecarbon dioxide absorption aid is predominantly water and the form of theabsorption aid is a hydrogel, there will be less evaporation of waterfrom the surface thereof in comparison with a solution or the like, andhence there will be little decrease in the efficiency of dissolution ofcarbon dioxide into the carbon dioxide-dissolving medium, wherebycosmetic and medical effects can be readily obtained.

With the carbon dioxide external administration device of the presentinvention, it is preferable for the carbon dioxide-dissolving medium tocomprise an emulsion or cream comprising at least an oil or a fat, asurfactant and water.

It is preferable for the carbon dioxide absorption aid to comprise anemulsion or cream comprising at least an oil or a fat, a surfactant andwater, since the emulsion or cream readily penetrates into the stratumcorneum, whereby not only is the carbon dioxide absorbed efficiently,but moreover cosmetic effects such as whitening and moisturizing areenhanced.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic drawing of the constitution of a carbon dioxideexternal administration device according to the present invention.

FIG. 2 is a schematic drawing of the constitution of a carbon dioxideexternal administration device according to the present invention.

FIG. 3 is a schematic drawing of the constitution of a carbon dioxideexternal administration device according to the present invention.

FIG. 4 is a schematic drawing of the constitution of a carbon dioxideexternal administration device according to the present invention.

FIG. 5 is a perspective drawing of sealing enclosure members that can beused in a carbon dioxide external administration device according to thepresent invention.

FIG. 6 is a schematic drawing of the constitution of a carbon dioxideexternal administration device according to the present invention.

FIG. 7 is a schematic drawing of the constitution of a carbon dioxideexternal administration device according to the present invention.

BEST MODE FOR CARRYING OUT THE INVENTION

Following is a description of embodiments of the present invention, withreference to the drawings.

A carbon dioxide external administration device 1 of the presentinvention is constituted from at least a sealing enclosure member 2capable of sealing a body surface from the outside air, a supply means 3for supplying carbon dioxide into the inside of the sealing enclosuremember 2, and an absorption aid 4 that assists transdermal ortransmucosal absorption of the carbon dioxide inside the sealingenclosure member 2. Note, however, that the sealing enclosure member 2does not necessarily have to seal the body surface from the outside aircompletely, but rather it is sufficient so long as the carbon dioxideconcentration inside the sealing enclosure member 2 can be maintainedabove a certain level by continually supplying a small amount of carbondioxide into the sealing enclosure member 2.

With the carbon dioxide external administration device 1 of the presentinvention, there are no particular limitations on the shape, materialsand so on of the sealing enclosure member 2, so long as the sealingenclosure member 2 covers the skin or mucosae and has therein a certainspace in which carbon dioxide is held.

Regarding the shape, for example a bag that can completely pack a hand(or a foot) as shown in FIG. 1, and a tubular bag that wraps around anarm (or a leg) as shown in FIG. 2 can be used. Moreover, as the shape ofthe sealing enclosure member 2, a vessel having an open hemline thatadheres to a relatively large area of the skin surface such as theabdomen or the like as shown in FIG. 3, or a cup-shaped tubular bodythat has one end thereof open and the other end thereof made to be apart connecting to the supply means 3 as shown in FIG. 4 can be used. Ofcourse, the shape of the sealing enclosure member 2 is not limited tothese examples.

There are no particular limitations on the materials of the sealingenclosure member 2 so long as these materials are impermeable to gases;materials can be selected from metal, plastic, rubber, glass and so onand used as appropriate in accordance with the purpose, the site of useand so on.

In the case that the sealing enclosure member 2 is one made of only anon-elastic and hard material such as metal or glass (hereinafterreferred to as a ‘rigid sealing enclosure member’), a shape havingtherein a certain sealed space surrounding the site of use ispreferable. The part contacting with the skin or mucosae preferably hasa shape conforming to the site of use so that carbon dioxide will notleak out; combining with an elastic material such as rubber or a resinfor the part contacting with the skin or mucosae is preferable since itwill be possible to flexibly respond to the site of use. The combinationwith a material that has higher flexibility and excellent adhesion toskin or mucosae such as a viscoelastic gel is more preferable.

Moreover, to fill carbon dioxide into the sealed space in which the skinor mucosae is sealed by the rigid sealing enclosure member, theenclosure member preferably has a gas outlet therein. When injectingcarbon dioxide into the sealed space, air in the sealed space escapesout from a gap in the part contacting with the skin or mucosae and theair is replaced with carbon dioxide. But the adjustment of the size ofthe gap is so hard that it is difficult to carry out the replacementreliably, and the amount of carbon dioxide required for the replacementisn't fixed. For example, by providing a gas outlet in, a positionfurthest from the gas inlet, the replacement of the air with carbondioxide can be carried out efficiently in a short period of time.

The gas inlet 2 a in the rigid sealing enclosure member (see FIGS. 3 and4) has connected thereto a tube 3 a that is connected to the supplymeans 3; there are no particular limitations on the gas inlet 2 a solong as gas will not leak therefrom, but one equipped with a check valvefor preventing back flow of gas is more preferable. Regarding the gasoutlet 2 b in the rigid sealing enclosure member (see FIGS. 3 and 4), agap in the part contacting with the skin or mucosae may be used, but tocarry out the replacement of the air inside the enclosure member withcarbon dioxide reliably and efficiently, a gas outlet equipped with acheck valve for preventing back flow of gas is more preferable.

In the case that the sealing enclosure member 2 is one made of amaterial that is a flexible material such as a rubber, a resin or a softplastic, especially, a material that has a shape holding ability, bywhich the shape is barely kept by some external force (hereinafterreferred to as a ‘flexible sealing enclosure member’), the partcontacting with the skin or mucosae is also flexible, and hence theabove material can be used as is. However, the combination with amaterial that has yet higher flexibility and excellent adhesion to skinor mucosae such as a viscoelastic gel for the part contacting with theskin or mucosae is more preferable. Moreover, with such a flexiblesealing enclosure member, the same gas inlet and gas outlet as those inthe case of a rigid sealing enclosure member can be used.

In the case that the sealing enclosure member 2 is one made of amaterial that is a flexible material such as a rubber or a resin,especially a material that is elastic highly like a balloon (hereinafterreferred to as an ‘elastic sealing enclosure member’), this can be usedin the form of a tube, a bag or the like, with the skin or mucosae beingsealed by binding the mouth of the tube, bag or the like covering thedesired site, or providing a retractable opening/closing mouth in whichrubber, a spring or the like is placed in the mouth.

Moreover, in the case of a tubular elastic sealing enclosure member forwhich the site of application is made to be, for example, an arm, thecircumference of the tube may be made to be approximately the same asthat of the arm, or may be made smaller, with the skin or mucosae beingsealed in a state with the sealing enclosure member adhering to the skinor mucosae, or a state with only a very small space between the sealingenclosure member and the skin or mucosae; carbon dioxide may then beinjected between the sealing enclosure member and the skin or mucosae soas to expand the sealing enclosure member, and the certain space inwhich carbon dioxide may be held is created by the carbon dioxideitself.

A gas inlet and gas outlet of the elastic sealing enclosure member mayhave the same structure as with the aforementioned rigid sealingenclosure member, but alternatively it is possible to seal the skin ormucosae with a tube, a bag or the like, and discharge the air therein asmuch as possible in advance, and then insert the tube 3 a in from theorifice of the elastic sealing enclosure member having the form of atube, a bag or the like such that air is prevented from entering thereinas much as possible, and inject carbon dioxide (see FIGS. 1 and 2).

In the case that the sealing enclosure member 2 is one made of afoldable sheet- or film-like material (hereinafter referred to as a‘sheet-type sealing enclosure member’), this can be used in the form ofa tube, a bag or the like, with the skin or mucosae being sealed bybinding the orifice of the tube, the bag or the like covering thedesired site, or providing a retractable opening/closing orifice inwhich rubber, a spring or the like is placed in the orifice.

Moreover, in the case of a tubular sheet-type sealing enclosure memberfor which the site of application is made to be, for example, an arm (ora leg), it is possible to make the circumference of the tube be greaterthan that of the arm, seal the arm and fold the sealing enclosuremember, so as to discharge air therein as much as possible in advance,and then use the sealing enclosure member with adhering to the skin ormucosae. A gas inlet and gas outlet of the sealing enclosure member maybe as with the rigid sealing enclosure member, but alternatively it ispossible to seal the skin or mucosae with the tube, bag or the like, anddischarge the air therein as much as possible in advance, and theninsert a tube in from the orifice of the sheet-type sealing enclosuremember having the form of a tube, a bag or the like such that air isprevented from entering there in as much as possible, and inject carbondioxide.

FIG. 5 shows an example of sealing enclosure members 2 that can besuitably used in the present invention.

These sealing enclosure members 2 comprise a right and left pair ofstorage boxes 21 made of a transparent or translucent synthetic resin; atube 3 a possessing a valve 31 is connected to the storage boxes 21,whereby carbon dioxide from the supply means 3 can be supplied to eitheror both of the storage boxes 21.

Each storage box 21 comprises a box body 22 that is open at the top andin a side wall thereof a cut-out concave portion 22 a, through which awrist can be inserted, is formed, and a detachable lid member 23 thatcovers the upper opening of the box body 22; a sealing member 24 made ofa flexible material such as sponge is attached around the rim of thecut-out concave portion 22 a. Moreover, although not shown in FIG. 5, asealing member made of a flexible material such as sponge is alsoattached to the place corresponding to the cut-out concave portion 22 aof the rim of the rear surface of the lid member 23.

FIGS. 6 and 7 show carbon dioxide external administration devices 1according to other embodiments of the present invention.

With each of the administration devices 1 in this case, a carbon dioxideamount indicator 5 that expands upon carbon dioxide being supplied intothe sealing enclosure member 2 and contracts by the decrease of carbondioxide is attached to an upper end of the sealing enclosure member 2,whereby transdermal or transmucosal absorption of carbon dioxide caneasily be checked upon from the outside even without specializedknowledge or the like.

Moreover, of the administration devices 1 shown in FIGS. 6 and 7, withthe administration device 1 shown in FIG. 6, a balloon indicator 5 madeof rubber or another elastic material is used, and with theadministration device 1 shown in FIG. 7, a bellows-structured indicator5 that is retractable in a vertical direction is used.

With the carbon dioxide external administration device 1 of the presentinvention, there are no particular limitations on the carbon dioxidesupply means 3; for example, a commercially available carbon dioxide gascylinder or the like can be used. Moreover, there may be used, forexample, a device that uses a closed vessel having a tube attachedthereto, wherein so-called dry ice, which is solid carbon dioxide, isvaporized inside the vessel, or carbon dioxide is generated inside thevessel through reaction between a carbonate and an acid, and the like.

With the carbon dioxide external administration device 1 of the presentinvention, regarding the tube 3 a connecting the sealing enclosuremember 2 to the carbon dioxide supply means 3, there are no particularlimitations so long as the tube is such that gas will not leak out, andany material from which a tube can be formed, for example, rubber, aresin, metal or glass, may be used.

With the carbon dioxide external administration device 1 of the presentinvention, there are no particular limitations on a sheet-like productused for the carbon dioxide absorption aid 4, so long as this sheet-likeproduct can be impregnated with a liquid containing at least water andcan be patched on skin or mucosae; examples thereof include woven andnonwoven cloths made of natural fibers, synthetic fibers, semi-syntheticfibers or the like, semi-permeable membranes such as cellulosemembranes, and hydrogel sheets made of a natural polymer, a syntheticpolymer, a semi-synthetic polymer or the like, and one or more of thesemay be used.

There are no particular limitations on the aforementioned liquidcontaining at least water; this liquid may be water itself, or so longas the effects of the present invention are not impaired, may be waterhaving some substances dissolved or dispersed therein.

Moreover, the liquid containing at least water preferably has a pH of 7to 2, and more preferably is acidic water having a pH of 6.5 to 4. Thereason is that when carbon dioxide is dissolved in an acidic solvent ofpH of not less than 4, the carbon dioxide is transdermally ortransmucosally absorbed efficiently.

With the carbon dioxide external administration device 1 of the presentinvention, a viscous material used for the carbon dioxide absorption aid4 may be liquid or semi-solid, so long as the viscous material containswater and does not easily run off or after having been applied onto theskin or mucosae, and has a viscosity of not less than 20 cps at 20° C.;examples of forms include liquids, creams, pastes and gels; and one ormore of these may be used.

Moreover, the viscous material preferably has a pH of 7 to 2, and morepreferably is an acidic viscous material having a pH of 6.5 to 4.

There are no particular limitations on the viscous material, but thewater content is preferably as high as possible, and moreover it ispreferable to be one that is able to replenish moisture in the skin ormucosae. As a liquid, an aqueous solution, suspension, swelling liquidor the like of a thickener may be suitably used, because the requiredviscosity can be obtained with a small amount, and adhesion or viscosityto skin or mucosae is excellent. There are no particular limitations onthe production method thereof, with it being possible to use a knownmethod.

There are no particular limitations on a cream, a paste or a gel; oneproduced using a known method can be used.

As the thickener used in the viscous material, at least one selectedfrom the group consisting of natural polymers, semi-synthetic polymers,synthetic polymers and inorganic materials can be used.

Examples of natural polymers include plant-derived polymers such as gumarabic, carrageenan, galactan, agar, xanthan gum, quince seed gum, guargum, tragacanth, pectin, mannan, locust bean gum, wheat starch, ricestarch, corn starch and potato starch, microorganism-derived polymerssuch as curdlan, xanthan gum, succinoglucan, dextran, hyaluronic acidand pullulan, and protein-type polymers such as albumin, casein,collagen, gelatin and fibroin; one or more of these can be used. Ofthese, from the standpoint of affinity with skin and mucosae and so on,gum arabic, carrageenan, xanthan gum, tragacanth, hyaluronic acid,pullulan, pectin, mannan and locust bean gum can be preferably used, andfrom the standpoint of feeling in use and so on, carrageenan and pectincan be more preferably used.

Examples of semi-synthetic polymers include cellulosic polymers such asethylcellulose, carboxymethylcellulose, carboxymethylethylcellulose,carboxymethyl starch, croscarmellose, crystalline cellulose, celluloseacetate, cellulose acetate phthalate, hydroxyethylcellulose,hydroxypropylcellulose, hydroxypropylmethylcellulose,hydroxypropylmethylcellulose phthalate, methylcellulose andmethylhydroxypropylcellulose, starch-type polymers such aspregelatinized starch, partially pregelatinized starch, carboxymethylstarch, dextrin, methyl starch, starch-acrylic acid copolymers andcellulose-acrylonitrile graft copolymers, alginate-type polymers such assodium alginate and propylene glycol alginate, and otherpolysaccharide-type polymers such as chondroitin sulfate sodium andsodium hyaluronate; one or more of these can be used.

Of these, from the standpoint of affinity with skin and mucosae and soon, sodium alginate, propylene glycol alginate, sodiumcarboxymethylcellulose, dextrin and sodium hyaluronate can be preferablyused, and from the standpoint of feeling in use and so on, sodiumalginate, propylene glycol alginate and sodium hyaluronate can be morepreferably used.

Examples of synthetic polymers include carboxyvinyl polymers, sodiumpolyacrylate, polyamines, polyacrylamide, polyvinylacetaldiethylaminoacetate, polyvinyl alcohol, polyvinyl pyrrolidone,polyethylene glycol, polyethylene oxide, poly(meth)acrylic acid,polyvinyl methyl ether and so on; one or more of these can be used. Ofthese, from the standpoint of affinity with skin and mucosae and so on,carboxyvinyl polymers, sodium polyacrylate, polyacrylamide, polyvinylalcohol and polyvinyl pyrrolidone can be preferably used, and from thestandpoint of feeling in use and so on, polyvinyl alcohol, polyvinylpyrrolidone and carboxyvinyl polymers can be more preferably used.

Examples of inorganic materials include hydrated silicon dioxide, lightanhydrous silicic acid, colloidal alumina, bentonite, laponite and soon; one or more of these can be used. With the carbon dioxide externaladministration device 1 of the present invention, there are noparticular limitations on an alcohol having a high vaporizationtemperature used in the carbon dioxide absorption aid 4, so long as thisalcohol is liquid or semi-solid at room temperature and does not readilyvaporize at the skin temperature of a human; examples thereof includemonohydric alcohols such as isopropyl alcohol and 1-butanol, andpolyhydric alcohols such as ethylene glycol, diethylene glycol,polyethylene glycol, propylene glycol, dipropylene glycol,1,3-butanediol, 1,2-pentanediol, isoprene glycol, glycerol, diglycerol,triglycerol and tetraglycerol; one or more of these can be used. Thereare no particular limitations on the method of using the alcohol havinga high vaporization temperature; in accordance with the physicalproperties thereof and so on, the alcohol may be applied or sprayed ontothe skin or mucosae as is, or impregnated or the like into a nonwovencloth or the like and then patched on.

With the carbon dioxide external administration device 1 of the presentinvention, there are no particular limitations on an oil or a fat usedin the carbon dioxide absorption aid 4, so long as this oil or fat isliquid or semi-solid at room temperature and can be applied relativelythinly onto the skin or mucosae; examples thereof include naturalvegetable oils and fats such as avocado oil, avocado butter, olive oil,sesame oil, safflower oil, soybean oil, camellia oil, sunflower oil andmacadamia nut oil, and animal oils and fats such as squalane, mink oil,beef tallow, lard, chicken fat and horse fat; one or more of these canbe used.

There are no particular limitations on the method of using an oil or afat; in accordance with the physical properties thereof and so on, theoil or the fat may be applied or sprayed onto the skin or mucosae as is,or impregnated or the like into a nonwoven cloth or the like and thenpatched on.

With the carbon dioxide external administration device 1 of the presentinvention, there are no particular limitations on a wax used in thecarbon dioxide absorption aid 4, so long as this wax is liquid orsemi-solid at room temperature and can be applied relatively thinly ontothe skin or mucosae; examples thereof include jojoba oil, carnauba wax,candelilla wax, beeswax and lanolin; one or more of these can be used.

There are no particular limitations on the method of using the wax; inaccordance with the physical properties thereof and so on, the wax maybe applied or sprayed onto the skin or mucosae as is, or impregnated orthe like into a nonwoven cloth or the like and then patched on.

With the carbon dioxide external administration device 1 of the presentinvention, when the carbon dioxide absorption aid 4 is applied to theskin or mucosae, it is preferable to form a film of the carbondioxide-dissolving medium on the skin or mucosae as thin as possible.When the film of the carbon dioxide-dissolving medium is too thick, ittakes time for the carbon dioxide to dissolve in the medium, and todiffuse and be absorbed into the skin or mucosae, and hence the carbondioxide absorption efficiency may be poor. However, in the case that thevaporization temperature of the carbon dioxide-dissolving medium isrelatively low, when the film of the carbon dioxide-dissolving mediumformed is too thin, the medium may vaporize or evaporate due to the skintemperature and hence may be lost from the skin or mucosae while thecarbon dioxide is being absorbed; the amount of the carbondioxide-dissolving medium to be used must thus be suitably adjusted.

Raw materials commonly used in external preparations and cosmetics, forexample fragrances, colorants, surfactants, oils, moisturizers,alcohols, preservatives, antioxidants, sequestering agents,anti-colorants, ultraviolet absorbing/scattering agents, vitamins, aminoacids, drugs such as arbutin, kojic acid, nutrients,anti-inflammatories, vasodilators, hormones, astringents,antihistamines, microbicides, sebum inhibiting agents, keratinstripping/dissolving agents, anti-seborrheic agents and antipruritics,and so on, may be blended into the carbon dioxide absorption aid 4,whereby the carbon dioxide absorption aid 4 can be used yet moresuitably for a cosmetic or medical purpose.

With the carbon dioxide external administration device 1 of the presentinvention, the carbon dioxide used is gaseous, and the proportion ofcarbon dioxide in the gas is preferably not less than 10%, morepreferably not less than 30%. The amount of carbon dioxide to beadministered is preferably not less than 0.1 mg, more preferably notless than 0.3 mg, per square centimeter of the skin or mucosae.

Following is a more concrete description of the present invention givingexamples; however, the present invention is not limited to theseexamples.

EXAMPLE 1

(Sealing Enclosure Member 2)

As shown in FIG. 1, the end of a 15 cm×30 cm transparent polyethylenebag was bound with a rubber band, thus producing a sealing enclosuremember.

(Carbon Dioxide Supply Means 3)

A commercially available carbon dioxide gas cylinder for aquatic plantcultivation (trade name Tetra CO2 gas cylinder, made by Warner Lambert)was used.

(Carbon Dioxide Absorption Aid 4)

A carbon dioxide absorption aid 4 was produced by soaking a 0.5% aqueouscitric acid solution into a polypropylene nonwoven cloth to an extentsuch that the water did not drip out.

The absorption aid 4 was cut into a 5 cm×5 cm square, and was patchedonto the skin of the back of the left hand of a 46-year-old male, andthe left hand was covered with the sealing enclosure member 2, and theair therein was removed. A vinyl tube of outside diameter 6.0 mm, insidediameter 3.5 mm and length 60 cm having one end thereof connected to thecarbon dioxide jet of the carbon dioxide supply means 3 was insertedinto the sealing enclosure member 2. The mouth of the sealing enclosuremember 2 was bound with a rubber band at the wrist part and thus sealed.100 ml of carbon dioxide was filled into the sealing enclosure member 2from the carbon dioxide supply means 3, and then the system was left for5 minutes.

After 5 minutes, the left hand was removed from the sealing enclosuremember 2, whereupon the skin under the carbon dioxide absorption aid 4had reddened in a square shape matching that of the absorption aid 4.After 2 minutes, the reddening disappeared, and the square of skinturned very white, and a moistness was felt.

The water on the site on which the carbon dioxide absorption aid 4 hadbeen patched was completely wiped off, and after 10 minutes the skinmoisture content and sebum content were measured using a facial analyzer(made by Corefront Corporation; measures the skin moisture content andthe sebum content in a range of 0 to 99).

The skin onto which the carbon dioxide absorption aid 4 of the presentexample had been applied had a skin moisture content of 71 and a sebumcontent of 48, which were clearly increased compared with a skinmoisture content of 19 and a sebum content of 4 for the back of theuntreated right hand, correlating to the feeling of moistness.

The skin surface was observed at a magnification of 40× using a CCDcamera, whereupon at the site of application of the carbon dioxideabsorption aid of the present example, compared with the skin on theback of the untreated right hand, the skin grooves and mounds wereclearer, and the skin texture had become finer.

EXAMPLE 2

(Sealing Enclosure Member 2)

As shown in FIG. 2, both ends of a transparent tubular polyethylene baghaving a circumference of 30 cm and a length of 20 cm were bound withelastic cord, thus producing a sealing enclosure member.

(Carbon Dioxide Supply Means 3)

A commercially available carbon dioxide gas cylinder for aquatic plantcultivation (trade name Tetra CO2 gas cylinder, made by Warner Lambert)was used.

(Carbon Dioxide Absorption Aid 4)

A viscous material was prepared using 1.8 parts by weight of sodiumalginate and 1 part by weight of sodium carboxymethyl cellulose asthickeners, 0.2 part by weight of methylparaben as a preservative, and97 parts by weight of purified water as water, and this viscous materialwas used as a carbon dioxide absorption aid 4.

1 g of the aforementioned absorption aid 4 was applied onto the whole ofthe right upper arm of a 26-year-old female, and this upper arm wascovered with the sealing enclosure member 2, and the air therein wasremoved. A vinyl tube of outside diameter 6.0 mm, inside diameter 3.5 mmand length 60 cm having one end thereof connected to the carbon dioxidejet of the carbon dioxide supply means 3 was inserted into the sealingenclosure member 2. Both ends of the sealing enclosure member 2 werebound with elastic cord and thus sealed. 100 ml of carbon dioxide wasfilled into the sealing enclosure member from the carbon dioxide supplymeans 3, and then the system was left for 10 minutes.

After 10 minutes, the upper arm was removed from the sealing enclosuremember 2. The skin onto which the carbon dioxide absorption aid 4 hadbeen applied had reddened, and hence an increase in blood flow wasobserved. The absorption aid was immediately completely removed,whereupon after 2 minutes the reddening disappeared, and the skin turnedvery white, and a moistness was felt. The circumference of the centralpart of the upper arm was measured, whereupon this circumference haddecreased by 1.5 cm compared with that before the application of thecarbon dioxide absorption aid 4.

Furthermore, after 10 minutes the skin moisture content and sebumcontent were measured using the aforementioned facial analyzer. The siteonto which the carbon dioxide absorption aid 4 of the present examplehad been applied had a skin moisture content of 67 and a sebum contentof 44, which were clearly increased compared with a skin moisturecontent of 11 and a sebum content of 3 for the untreated left upper arm,correlating to the feeling of moistness.

EXAMPLE 3

(Sealing Enclosure Member 2)

A plastic box-shaped closed vessel as shown in FIG. 3 (length 10cm×width 4 cm×depth 3 cm, having suction rubber at the part thereofcontacting the human body, and a check valve for discharging gas frominside the vessel in the side thereof) was taken as a sealing enclosuremember.

(Carbon Dioxide Supply Means 3)

A commercially available carbon dioxide gas cylinder for aquatic plantcultivation (trade name Tetra CO2 gas cylinder, made by Warner Lambert)was used.

(Carbon Dioxide Absorption Aid 4)

A viscous material was prepared using 2 parts by weight of carrageenanand 1 part by weight of pectin as thickeners, 0.2 part by weight ofmethylparaben as a preservative, and 96.8 parts by weight of purifiedwater as water, and this viscous material was used as a carbon dioxideabsorption aid 4.

A suitable amount of the aforementioned viscous material was thinlyapplied onto itchy atopic dermatitis that had arisen on the right thighof a 13-year-old male (length approximately 5 cm×width approximately 3cm). The aforementioned plastic box-shaped closed vessel, a checkvalve-possessing gas inlet of which had been connected to the carbondioxide jet of the carbon dioxide gas cylinder by a vinyl tube ofoutside diameter 6.0 mm, inside diameter 3.5 mm and length 60 cm, wasplaced over the site in question, thus sealed the site.

150 ml of carbon dioxide was blown into the vessel from the gascylinder, thus driving out the air in the vessel from the check valvenot having the vinyl tube connected thereto, and then the system wasleft for 10 minutes. 1 minute after the carbon dioxide had been blownin, the atopic dermatitis turned red, and hence an increase in bloodflow was observed. After 10 minutes, the viscous material was completelyremoved, whereupon the redness quickly disappeared; the dryness of theatopic dermatitis was eliminated, and the itchiness also went away.

EXAMPLE 4

(Sealing Enclosure Member 2)

A plastic tubular body as shown in FIG. 4 was taken as a sealingenclosure member. This tubular body had a diameter of 3 cm and a lengthof 12 cm, had a check valve for discharging gas from inside the tubeprovided close to the tip of the tube, and had a carbon dioxideabsorption aid 4 attached to the tip of the tube.

(Carbon Dioxide Supply Means 3)

A commercially available carbon dioxide gas cylinder for aquatic plantcultivation (trade name Tetra CO2 gas cylinder, made by Warner Lambert)was used.

(Carbon Dioxide Absorption Aid 4)

A viscous liquid prepared using 2 parts by weight of sodium alginate asa thickener and 98 parts by weight of purified water as water was soakedinto a polyester nonwoven cloth of diameter 4 cm, and then the nonwovencloth was immersed in a 1% aqueous calcium chloride solution, thuspreparing a calcium alginate hydrogel membrane having a nonwoven clothas a support; this hydrogel membrane was used as the carbon dioxideabsorption aid 4.

The carbon dioxide absorption aid 4 was placed against the tip of thesealing enclosure member 2, folded around the sealing enclosure member2, and fixed with a thick rubber band. The absorption aid 4 was thenplaced against the pigmented spot of diameter approximately 1 cm on theleft cheek of a 42-year-old female, approximately 200 ml of carbondioxide was injected in from the carbon dioxide supply means 3, thusreplacing the air inside the sealing enclosure member 2 with carbondioxide, and then the system was left for 10 minutes. This was continuedonce per day for 2 weeks, whereupon the pigmented spot became fainter.

EXAMPLE 5

(Sealing Enclosure Member 2)

A sealing enclosure member 2 as shown in FIG. 5 was used.

More specifically, this sealing enclosure member was constituted from apolypropylene main vessel (length 20 cm×width 15 cm×depth 8 cm, having athree-way stopcock attached to a side thereof, having a cut of width 8cm×depth 6 cm in an edge thereof, and having in the cut a U-shapedsponge of thickness 4 cm×width 10 cm×height 7 cm having a 5 cm×5 cmcut-out therein, the sponge being fitted into the cut through the spongehaving a 1 cm-deep groove formed therein along a centerline of theoutside thereof), and a polyethylene lid having a sponge of width andheight 1 cm and length 10 cm glued by double-sided tape to a part of thelid that contacts the top of the cut in the main vessel.

(Carbon Dioxide Supply Means 3)

Liquefied carbon dioxide gas filled into a high-pressure gas cylinder(filling amount: 30 kg) was used.

(Carbon Dioxide Absorption Aid 4)

A carbon dioxide absorption aid 4 comprising a viscous materialcontaining water was prepared using 2.5 parts by weight of sodiumalginate and 1.2 parts by weight of sodium carboxymethyl cellulose asthickeners, 88.2 parts by weight of purified water as water, 0.1 part byweight of methylparaben as a preservative, and 1 part by weight ofsodium dihydrogen phosphate as a pH adjuster.

A suitable amount of the aforementioned carbon dioxide absorption aid 4was applied onto the abrasion of diameter 5 mm on the back of the lefthand of a 37-year-old female, the left hand was put into theaforementioned sealing enclosure member 2, and carbon dioxide wasinitially supplied into the sealing enclosure member 2 for 10 seconds ata rate of 200 mL/s from the aforementioned carbon dioxide supply means3, and then for 5 minutes at a rate of 20 mL/s. The aid was then washedoff, whereupon the pain previously felt upon contact with water hadcompletely gone, and hence a wound healing promoting effect wasobserved.

EXAMPLE 6

(Sealing Enclosure Members 2)

Sealing enclosure members 2 as shown in FIG. 5 were used.

(Carbon Dioxide Supply Means 3)

Liquefied carbon dioxide gas filled into a high-pressure gas cylinder(filling amount: 30 kg) was used.

(Carbon Dioxide Absorption Aid 4)

The same carbon dioxide absorption aid 4 as in Example 5 was spread to athickness of approximately 0.5 mm onto a flat plastic plate, and a 5%calcium chloride solution was poured on from above so as to convert thesodium alginate into a hydrogel, thus preparing a carbon dioxideabsorption aid 4 comprising a calcium alginate hydrogel on one side anda sodium alginate sol on the other side.

A 5 cm×5 cm square of the carbon dioxide absorption aid 4 was patchedonto the back of the left hand of a 48-year-old male, and with nothingpatched onto the back of the right hand, the two hands were putrespectively into the two sealing enclosure members 2 a and 2 b, andcarbon dioxide was initially supplied into the sealing enclosure members2 for 10 seconds at a rate of 200 mL/s from the carbon dioxide supplymeans 3, and then for 7 minutes at a rate of 20 mL/s.

Both hands of the male immediately became warm, but the back of the lefthand felt warmer than the back of the right hand. The absorption aid wassubsequently removed, whereupon the skin on the back of the left handhad become smooth and white, and hence whitening and skin beautificationeffects were observed.

EXAMPLES 7 to 11

(Sealing Enclosure Members 2)

Sealing enclosure members 2 as shown in FIG. 5 were used.

(Carbon Dioxide Supply Means 3)

Liquefied carbon dioxide gas filled into a high-pressure gas cylinder(filling amount: 30 kg) was used.

(Carbon Dioxide Absorption Aid 4)

(A) 1,3-Butylene glycol as an alcohol was dehydrated with calciumchloride, and then filtration was carried out with filter paper, thusproducing a carbon dioxide absorption aid 4 (Example 7).

(B) Olive oil as oils and fats was dehydrated with calcium chloride, andthen filtration was carried out with filter paper, thus producing acarbon dioxide absorption aid 4 (Example 8).

(C) Avocado butter, which is a kind of oils and fats, was used as acarbon dioxide absorption aid 4 (Example 9).

(D) An emulsion was prepared using 1 part by weight of cetyl alcohol,2.5 parts by weight of white petrolatum and 6 parts by weight ofsqualane as oils and fats, 2 parts by weight of stearic acid, 1 part byweight of POE (20) hardened castor oil and 1 part by weight of glycerylmonostearate as surfactants, 36.9 parts by weight of distilled water aswater, 0.1 part by weight of methylparaben as a preservative, and 4parts by weight of glycerol, 0.5 part by weight of sodium carboxymethylcellulose and 5 parts by weight of ethanol as other raw materials, andthis was used as a carbon dioxide absorption aid 4 (Example 10).

(E) Jojoba oil, which is a kind of wax, was used as a carbon dioxideabsorption aid 4 (Example 11).

The carbon dioxide absorption aids 4 defined in (A) to (E) above wereapplied thinly onto the back of the left hand of three females of ages25, 37 and 40 years and a male of age 48 years, and with nothing appliedto the back of the right hand, the hands were put respectively into thetwo sealing enclosure members 2 a and 2 b, and carbon dioxide wasinitially supplied into each of the sealing enclosure members 2 for 10seconds at a rate of 200 mL/s from the aforementioned carbon dioxidesupply means 3, and then for 7 minutes at a rate of 20 mL/s.

For all of the subjects, the skin temperature of both hands rose, butfor everyone the skin on the back of the left hand felt warmer, and theskin on the back of the left hand reddened, and hence vasodilation wasobserved. On the other hand, for all of the subjects, the skin on theback of the right hand on which nothing had been applied was not redimmediately after the carbon dioxide absorption aid 4 had been removed.

Immediately after the carbon dioxide absorption aid 4 was removed, forall of the subjects, the back of the left hand was whiter and smootherthan the back of the right hand, and hence whitening and skinbeautification effects were observed. Furthermore, the differentcombinations of the different absorption aids 4 out of theaforementioned (A) to (E) were applied onto the backs of the left andright hands of each subject, and carbon dioxide absorption was carriedout as before, whereupon the whitening effect was strongest for (D).

EXAMPLE 12

(Sealing Enclosure Member 2)

As shown in FIG. 6, a vinyl bottle of diameter 7 cm was cut sideways ina position 6 cm below the mouth, and thin sponge was glued around thecircumference of the cut edge using double-sided tape. A thin rubberballoon (e.g. a condom is suitable) was placed over the mouth of thebottle, and the mouth part was bound with a rubber band. A hole was madein the side of the bottle, a plastic carbon dioxide injecting tube 2 aof diameter 5 mm and length 3 cm was inserted in, and a tube 3 a wasconnected thereto, thus producing a sealing enclosure member 2.

(Carbon Dioxide Supply Means 3)

Liquefied carbon dioxide gas filled into a high-pressure gas cylinder(filling amount: 30 kg) was used.

(Carbon Dioxide Absorption Aid 4)

A carbon dioxide absorption aid 4 of pH 2.5 was prepared using 50 partsby weight of a 1.0% aqueous sodium hyaluronate solution as a thickener,1 part by weight of malic acid as an acid, and 49 parts by weight ofpurified water as water, and this was impregnated in an amount of 0.05 gper square centimeter into a cotton nonwoven cloth, thus producing acarbon dioxide absorption aid 4.

(Evaluation Test)

An 8 cm×8 cm square of the carbon dioxide absorption aid 4 was patchedonto the abdomen of a 48-year-old male, the sealing enclosure member 2was placed thereover, the part contacting the skin was slightly raisedup, and carbon dioxide was supplied in for 10 seconds at a rate of 200mL/s, thus replacing the air in the sealing enclosure member 2 withcarbon dioxide.

Next, the sealing enclosure member 2 was adhered to the skin, and carbondioxide was supplied in until the balloon 5 expanded. The system wasleft for 5 minutes, whereupon the balloon deflated, and hence thesealing enclosure member 2 was removed from the abdomen, whereupon theskin under the absorption aid 4 had reddened in a disk shape matchingthe shape of the part of the skin adhered to the sealing enclosuremember 2, and hence strong dilation of the blood vessels in the skin ofthe abdomen was observed. A few minutes after the absorption aid 4 hadbeen taken off, the redness of the skin of the abdomen disappeared, butnow this part turned white in a disk shape, and hence a whitening effectwas observed.

(Comparative Test)

In the above evaluation test, gas-impermeable wrapping film was usedinstead of the carbon dioxide absorption aid 4, whereupon reddeningoccurred in a circular shape due to the pressure with which the sealingenclosure member 2 was pushed against the skin, but reddening of theskin in a disk shape as in the above evaluation test was not observed,and hence vasodilation was not observed. Similarly, a whitening effectwas not observed either.

EXAMPLE 13

(Sealing Enclosure Members 2)

Sealing enclosure members 2 as in Example 5 were used.

(Carbon Dioxide Supply Means 3)

Liquefied carbon dioxide gas filled into a high-pressure gas cylinder(filling amount: 30 kg) was used.

(Carbon Dioxide Absorption Aid 4)

A carbon dioxide-dissolving medium comprising a viscous materialcontaining water was prepared using 1 part by weight of propylene glycolalginate and 1.2 parts by weight of sodium carboxymethyl cellulose asthickeners, 86.7 parts by weight of purified water as water, 0.1 part byweight of methylparaben as a preservative, and 1 part by weight ofsodium dihydrogen phosphate as a pH adjuster, and 0.04 g per squarecentimeter was impregnated into a cotton nonwoven cloth, thus preparinga carbon dioxide absorption aid 4.

(Evaluation Test)

A 5 cm×5 cm square of the carbon dioxide absorption aid 4 was patchedonto the back of the left hand of a 48-year-old male, and a cottonnonwoven cloth impregnated with 0.04 g per square centimeter of thecarbon dioxide absorption aid 4 in Example 6 was patched onto the backof the right hand. The two hands were put respectively into the twosealing enclosure members 2 a and 2 b, and carbon dioxide was initiallysupplied into each of the sealing enclosure members 2 for 10 seconds ata rate of 200 mL/s from the aforementioned carbon dioxide supply means3, and then for 7 minutes at a rate of 20 mL/s. Both hands of the maleimmediately became warm, and no difference was felt between the left andthe right.

Immediately after ceasing the supplying in of the carbon dioxide, therespective absorption aids were removed, whereupon the redness wasstronger for the skin on the back of the left hand than the skin on theback of the right hand, showing that the vasodilation effect wasstronger. The two hands were subsequently washed, whereupon for thebacks of both hands, the skin had become smooth and white at the part onwhich the absorption aid had been patched, and hence whitening and skinbeautification effects were observed, but in both cases the back of theleft hand was better than the right hand.

INDUSTRIAL APPLICABILITY

The present invention relates to a carbon dioxide externaladministration device, and can be used for readily obtaining assuredcosmetic and medical effects.

1. A carbon dioxide external administration device, characterized bycomprising: a sealing enclosure member capable of sealing a body surfacefrom the outside air; a supply means for supplying carbon dioxide intothe inside of the sealing enclosure member; and an absorption aid thatassists transdermal or transmucosal absorption of the carbon dioxideinside the sealing enclosure member.
 2. The carbon dioxide externaladministration device according to claim 1, characterized by having acarbon dioxide amount indicator that expands upon carbon dioxide beingsupplied into the sealing enclosure member, and contracts by thedecrease of carbon dioxide.
 3. The carbon dioxide externaladministration device according to claim 1 or 2, characterized in thatthe carbon dioxide absorption aid contains at least one carbondioxide-dissolving medium selected from the group consisting of water,alcohols having a high vaporization temperature, oils and fats, andwaxes.
 4. The carbon dioxide external administration device according toclaim 1, characterized in that the carbon dioxide absorption aid is asheet-like product impregnated with a liquid containing at least water.5. The carbon dioxide external administration device according to claim1, characterized in that the carbon dioxide absorption aid contains acarbon dioxide-dissolving medium comprising a viscous materialcontaining at least water.
 6. The carbon dioxide external administrationdevice according to claim 5, characterized in that the carbondioxide-dissolving medium comprising a viscous material containing atleast water contains at least one thickener selected from the groupconsisting of sodium alginate, propylene glycol alginate, carrageenan,sodium hyaluronate, pectin, polyvinyl alcohol and polyvinyl pyrrolidone.7. The carbon dioxide external administration device according to claim1, characterized in that the carbon dioxide absorption aid contains acarbon dioxide-dissolving medium comprising at least a calcium alginatehydrogel.
 8. The carbon dioxide external administration device accordingto claim 1, characterized in that the carbon dioxide absorption aidcontains a carbon dioxide-dissolving medium that is an emulsion or creamcomprising at least an oil or a fat, a surfactant and water.